NCT05398406

Brief Summary

Sixty patients with ASA (American Society of Anesthesiologist) I-II physical status between the ages of 20-60 were randomized into three groups: TAP block group (Group T), ESP block group (Group E) and PVB group (Group P). Bilateral 20cc (total 40cc for each patient) 0.25% bupivacaine was applied by ultrasound (US) guidance. Intraoperative vital signs (heart rate, blood pressure, and saturation), Train-of-four (TOF) values, additional dose of opioid and muscle relaxant needs, complications were recorded. Postoperative side effects (nausea, vomiting, itching, tremor), the need for additional postoperative analgesia, Visual Analog Scale (VAS) scores were noted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 17, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 1, 2022

Completed
Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

May 17, 2022

Last Update Submit

March 3, 2026

Conditions

Keywords

plane blocksultrasonographybupivacaine

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity measured by 10-cm Visual Analogue Scale (VAS)

    Pain intensity assessed using a 10-cm Visual Analogue Scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain.

    6 hours postoperatively

Secondary Outcomes (5)

  • Postoperative rescue analgesic requirement

    Within the first 6 hours postoperatively

  • Intraoperative opioid consumption

    During surgery

  • Intraoperative neuromuscular blocker requirement

    During surgery

  • Incidence of postoperative adverse events

    Within the first 6 hours postoperatively

  • Time to first mobilization

    Within the first 6 hours postoperatively

Study Arms (3)

Subcostal TAP Block

EXPERIMENTAL

In the supine position, the US probe was placed on the imaginary line connecting the anterior superior iliac spine (SIAS) and the umbilicus. The ilioinguinal and iliohypogastric nerves in the fascia of the internal obliq and transverse abdominis muscles were visualized by US. A total of 40 ml (20+20 ml) of local anesthetic was infiltrated around the nerve bilaterally with a 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®,USA).

Other: TAP Block group

ESP Block

EXPERIMENTAL

In the lateral decubitus position, a 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®,USA) was inserted between the erector spinae muscle and the transverse process structures in an in-plane section guided by US from the T7-8 level. A total of 40 ml of the prepared solutions were injected bilaterally as 20+20 ml.

Other: Erector spinae block group

Paravertebral block

EXPERIMENTAL

In the lateral decubitus position, the cranial to caudal transverse processes and the superior costotransverse ligament and the pleura were visualized from the T7-8 level in the in-plane section under US guidance. A 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®, USA) was advanced until it passed through the superior costotransverse ligament. A total of 40 ml of injections were made bilaterally in the form of 20+20 ml.

Other: Paravertebral block group

Interventions

TAP Block: the US probe was placed on the imaginary line connecting the anterior superior iliac spine and the umbilicus. The ilioinguinal and iliohypogastric nerves in the fascia of the internal obliq and transverse abdominis muscles were visualized by US. A total of 40 ml of local anesthetic was infiltrated ESP Blok : a 100 mm 21G peripheral nerve block needle was inserted between the erector spinae muscle and the transverse process structures in an in-plane section guided by US from the T7-8 level. 40 ml of the prepared solutions were injected PVB: In the lateral decubitus position, the cranial to caudal transverse processes and the superior costotransverse ligament and the pleura were visualized from the T7-8 level in the in-plane section under US guidance. A 100 mm 21G peripheral nerve block needle was advanced until it passed through the superior costotransverse ligament. A total of 40 ml of injections were made

Also known as: Paravertebral block group, Erector spinae block group
Subcostal TAP Block

In the lateral decubitus position, the cranial to caudal transverse processes and the superior costotransverse ligament and the pleura were visualized from the T7-8 level in the in-plane section under US guidance. A 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®, USA) was advanced until it passed through the superior costotransverse ligament. A total of 40 ml of injections were made bilaterally in the form of 20+20 ml.

Also known as: PVB group
Paravertebral block

In the lateral decubitus position, a 100 mm 21G peripheral nerve block needle (SonoPlex Stim Cannula, PAJUNK®,USA) was inserted between the erector spinae muscle and the transverse process structures in an in-plane section guided by US from the T7-8 level. A total of 40 ml of the prepared solutions were injected bilaterally as 20+20 ml.

Also known as: ESP block group
ESP Block

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years,
  • ASA I-II ,
  • scheduled for elective laparoscopic cholecystectomy
  • under general anesthesia,
  • agreed to participate in the study,

You may not qualify if:

  • under the age of 20 - over 60,
  • emerge and bleeding,
  • outside the ASAI-II functional status,
  • undergo surgery other than laparoscopic cholecystectomy,
  • refused to participate in the study, allergic to local anesthetic agents,
  • body mass index (BMI) \>30,
  • have contraindications for regional anesthesia (sepsis, local infection, coagulopathy, heart disease, hypovolemia, cases that do not want regional anesthesia),
  • pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Yuzuncu Yil University

Van, Tuşba, 65000, Turkey (Türkiye)

Location

Study Officials

  • Arzu E Tekeli, MD

    Yuzuncu Yil University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
This was a single-blind study. Participants and the investigator assessing postoperative outcomes were blinded to group allocation. The anesthesiologist performing the regional blocks was not involved in postoperative data collection.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: randomized, single-blind, closed-envelope method
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 17, 2022

First Posted

June 1, 2022

Study Start

January 1, 2020

Primary Completion

August 1, 2020

Study Completion

January 1, 2021

Last Updated

March 5, 2026

Record last verified: 2026-03

Locations